U.S. States Go After Teva And 19 Other Pharma Companies For Price Gouging Generic Drugs

May 11, 2019

Forty-four U.S. states have filed a lawsuit against 20 drug companies including Teva Pharmaceuticals USA Inc. They're accused of concocting a sweeping scheme to inflate drug prices and stifle competition for more than 100 generic drugs. The drugs treated conditions including diabetes, high cholesterol, high blood pressure, cancer, epilepsy and more.

Spotlight

Lifecare Innovations Private Limited

Lifecare Innovations is a R&D intensive company specialised in controlled release pharmaceuticals employing an array of technologies of novel drug delivery systems. The first product is a Liposome mediated delivery of Amphotericin B to target fungal or leishmania cells. Lifecare Innovations received Technology Day 2004 National Award for Bio-technology in recognition of the indigenous development and production of life saving drug - FUNGISOME. The award function was presided by His Excellency the President of India Dr. A.P.J. Abdul Kalam. The award and the citation were presented by the Minister of Science Technology and Ocean Development Mr. Kapil Sibbal. Lifecare Innovations is engaged in the development of number of other controlled release drugs in collaboration with national institutions. These are under various stages of development. Predominant among these are a range of anti-fungals. To complement anti-fungal treatment, Lifecare Innovations has also launched Itraconazole capsul

OTHER VIDEOS

Filling, closing and labeling compact machines for microtubes

video | November 28, 2022

Dara Pharma designs state-of-the-art solutions for processing diagnostics reagents. We offer different equipment for this format, which is often filled in tubes, microtubes,...

Watch Now

Revolutionizing visual inspection in pharma through AI

video | November 29, 2022

That is why we have launched our AI-powered visual inspection software solution with full commitment to help pharmaceutical companies improve their product quality while reducing False Rejects and costs to a minimum....

Watch Now

User-Friendly App for pharmaceutical deliveries to your doorstep

video | November 29, 2022

With just a few clicks get the convenience of pharmaceutical deliveries to your doorstep. Experience a user-friendly app!...

Watch Now

The Future of Pharmacy Management Software

video | November 17, 2022

Welcome to the future of pharmacy management software! Axys is built from the ground up on the most modern technology. Not the most modern technology in long-term care....

Watch Now

Spotlight

Lifecare Innovations Private Limited

Lifecare Innovations is a R&D intensive company specialised in controlled release pharmaceuticals employing an array of technologies of novel drug delivery systems. The first product is a Liposome mediated delivery of Amphotericin B to target fungal or leishmania cells. Lifecare Innovations received Technology Day 2004 National Award for Bio-technology in recognition of the indigenous development and production of life saving drug - FUNGISOME. The award function was presided by His Excellency the President of India Dr. A.P.J. Abdul Kalam. The award and the citation were presented by the Minister of Science Technology and Ocean Development Mr. Kapil Sibbal. Lifecare Innovations is engaged in the development of number of other controlled release drugs in collaboration with national institutions. These are under various stages of development. Predominant among these are a range of anti-fungals. To complement anti-fungal treatment, Lifecare Innovations has also launched Itraconazole capsul

Events